These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 39173918)

  • 21. [Community- and non-community-acquired bacteremia: correlation between empiric antimicrobial therapy and susceptibility of micro-organisms isolated during 2007 in the Ile-de-France microbiologists network].
    Porcheret H; Barraud D; Bingen M; Rabenja T; Costa Y; Estève V; Faibis F; Demachy MC; Scanvic A; Vallée E; Péan Y
    Pathol Biol (Paris); 2010 Apr; 58(2):e7-e14. PubMed ID: 19875246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical outcomes of children with carbapenem-resistant Acinetobacter baumannii bacteremia.
    Vandepitte WP; Berge J; Andersson R
    J Med Assoc Thai; 2014 Nov; 97 Suppl 11():S129-39. PubMed ID: 25509707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The changing epidemiology of Staphylococcus aureus bloodstream infection: a multinational population-based surveillance study.
    Laupland KB; Lyytikäinen O; Søgaard M; Kennedy KJ; Knudsen JD; Ostergaard C; Galbraith JC; Valiquette L; Jacobsson G; Collignon P; Schønheyder HC;
    Clin Microbiol Infect; 2013 May; 19(5):465-71. PubMed ID: 22616816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High levels of discordant antimicrobial therapy in hospital-acquired bloodstream infections is associated with increased mortality in an intensive care, low antimicrobial resistance setting.
    Waagsbø B; Stuve N; Afset JE; Klepstad P; Mo S; Heggelund L; Damås JK
    Infect Dis (Lond); 2022 Oct; 54(10):738-747. PubMed ID: 35708021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The epidemiology of bloodstream infection contributing to mortality: the difference between community-acquired, healthcare-associated, and hospital-acquired infections.
    Mun SJ; Kim SH; Kim HT; Moon C; Wi YM
    BMC Infect Dis; 2022 Apr; 22(1):336. PubMed ID: 35382769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence and antimicrobial resistance trends in bloodstream infections caused by ESKAPE and Escherichia coli at a large teaching hospital in Rome, a 9-year analysis (2007-2015).
    De Angelis G; Fiori B; Menchinelli G; D'Inzeo T; Liotti FM; Morandotti GA; Sanguinetti M; Posteraro B; Spanu T
    Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1627-1636. PubMed ID: 29948360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for mortality in Acinetobacter baumannii bloodstream infections and development of a predictive mortality model.
    Corcione S; Longo BM; Scabini S; Pivetta E; Curtoni A; Shbaklo N; Costa C; De Rosa FG
    J Glob Antimicrob Resist; 2024 Sep; 38():317-326. PubMed ID: 39029658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of Tigecycline or Cefoperazone/Sulbactam therapy for bloodstream infection due to Carbapenem-resistant
    Niu T; Luo Q; Li Y; Zhou Y; Yu W; Xiao Y
    Antimicrob Resist Infect Control; 2019; 8():52. PubMed ID: 30886705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current trends in antimicrobial resistance of ESKAPEEc pathogens from bloodstream infections - Experience of a tertiary care centre in North India.
    Gupta M; Gupta V; Gupta R; Chaudhary J
    Indian J Med Microbiol; 2024; 50():100647. PubMed ID: 38871082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bloodstream infections in a secondary and tertiary care hospital setting.
    Raymond NJ; Blackmore TK; Humble MW; Jones MR
    Intern Med J; 2006 Dec; 36(12):765-72. PubMed ID: 17096739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors for carbapenem-resistant Acinetobacter baumanii blood stream infections in a neonatal intensive care unit, Delhi, India.
    Kumar A; Randhawa VS; Nirupam N; Rai Y; Saili A
    J Infect Dev Ctries; 2014 Aug; 8(8):1049-54. PubMed ID: 25116673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nosocomial bloodstream infections caused by Acinetobacter species in United States hospitals: clinical features, molecular epidemiology, and antimicrobial susceptibility.
    Wisplinghoff H; Edmond MB; Pfaller MA; Jones RN; Wenzel RP; Seifert H
    Clin Infect Dis; 2000 Sep; 31(3):690-7. PubMed ID: 11017817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Community-acquired bloodstream infections caused by Acinetobacter baumannii: A matched case-control study.
    Chen CT; Wang YC; Kuo SC; Shih FH; Chen TL; How CK; Yang YS; Lee YT
    J Microbiol Immunol Infect; 2018 Oct; 51(5):629-635. PubMed ID: 28701266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multidrug-resistant organism bloodstream infection and hospital acquisition among inpatients in three tertiary Greek hospitals during the COVID-19 era.
    Karakosta P; Vourli S; Kousouli E; Meletis G; Tychala A; Louka C; Vasilakopoulou A; Protonotariou E; Mamali V; Zarkotou O; Skoura L; Pournaras S
    Eur J Clin Microbiol Infect Dis; 2024 Jun; 43(6):1241-1246. PubMed ID: 38530465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A 21-Year Survey of Escherichia coli from Bloodstream Infections (BSI) in a Tertiary Hospital Reveals How Community-Hospital Dynamics of B2 Phylogroup Clones Influence Local BSI Rates.
    Rodríguez I; Figueiredo AS; Sousa M; Aracil-Gisbert S; Fernández-de-Bobadilla MD; Lanza VF; Rodríguez C; Zamora J; Loza E; Mingo P; Brooks CJ; Cantón R; Baquero F; Coque TM
    mSphere; 2021 Dec; 6(6):e0086821. PubMed ID: 34935444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carbapenem-resistant versus carbapenem-susceptible Acinetobacter baumannii bacteremia in a Greek intensive care unit: risk factors, clinical features and outcomes.
    Routsi C; Pratikaki M; Platsouka E; Sotiropoulou C; Nanas S; Markaki V; Vrettou C; Paniara O; Giamarellou H; Roussos C
    Infection; 2010 Jun; 38(3):173-80. PubMed ID: 20224962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genotypic analysis of Acinetobacter bloodstream infection isolates in a Turkish university hospital.
    Alp E; Esel D; Yildiz O; Voss A; Melchers W; Doganay M
    Scand J Infect Dis; 2006; 38(5):335-40. PubMed ID: 16709534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A nationwide population-based study of Escherichia coli bloodstream infections: incidence, antimicrobial resistance and mortality.
    Feldman SF; Temkin E; Wullfhart L; Nutman A; Schechner V; Shitrit P; Shvartz R; Schwaber MJ; Andremont A; Carmeli Y
    Clin Microbiol Infect; 2022 Jun; 28(6):879.e1-879.e7. PubMed ID: 34922002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of healthcare-associated acquisition on community-onset Gram-negative bloodstream infection: a population-based study: healthcare-associated Gram-negative BSI.
    Al-Hasan MN; Eckel-Passow JE; Baddour LM
    Eur J Clin Microbiol Infect Dis; 2012 Jun; 31(6):1163-71. PubMed ID: 21983895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors and impact of nosocomial Acinetobacter baumannii bloodstream infections in the adult intensive care unit: a case-control study.
    Jang TN; Lee SH; Huang CH; Lee CL; Chen WY
    J Hosp Infect; 2009 Oct; 73(2):143-50. PubMed ID: 19716203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.